|
Adult protocerebral MPP tachykinin neuron
|
Adult neuron that expresses tachykinin (FBgn0037976) and whose cell body is located in the median posterior protocerebrum. One cluster of around 3 cell bodies is found per hemisphere (Winther et al., 2003).
|
ILX:0100380
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Adult rat
|
A rat > or equal to 60 days old (day of birth defined as day 0) or > /
|
ILX:0100381
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Adult tachykinin neuron of the central nervous system
|
An adult neuron that expresses tachykinin (FBgn0037976) and that is located in the central nervous system (Winther et al., 2003).
|
ILX:0100382
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Adult tachykinin neuron of the thoracic-abdominal ganglion
|
Adult neuron that expresses tachykinin (FBgn0037976) whose cell body is located in the thoracic-abdominal ganglion. There are 10 to 12 pairs in the prothoracic, 5 to 6 in the mesothoracic, 8 to 12 in the metathoracic and 1 to 2 in the abdominal neuromeres (Winther et al., 2003).
|
ILX:0100383
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Adult tritocerebral TC1 tachykinin neuron
|
Adult neuron that expresses tachykinin (FBgn0037976), whose cell body is located in the tritocerebrum and which innervates, among other regions, the fan-shaped body. One cluster of around 16 cell bodies is found per hemisphere (Winther et al., 2003).
|
ILX:0100384
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Adult xenopus
|
A xenopus of age greater than or equal to 1 year, with the day of birth defined as day 0 or the stage of being a fully formed animal, following Nieuwkoop and Faber stage 66 (Xenopus ontology: http://purl.org/obo/owl/XAO#XAO_1000009).
|
ILX:0100385
|
4
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Advanced phase
|
A phase which is earlier than the natural start time.
|
ILX:0100386
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Aeolididina
|
|
ILX:0100387
|
4
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Aerobic
|
A quality inhering in a bearer by virtue of its dependence on oxygen.
|
ILX:0100388
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Aerobic (for occurrence)
|
A quality inhering in a biological process by virtue of the process unfolding in a location with oxygen.
|
ILX:0100389
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Affective assessment
|
An neuropsychiatric instrument consisting of a series of patient-answer and/or clinician-answered questions designed to assess the affective state of the patient. Typically score ranges are mapped to particular stages or states along an affective continuum such as depressive state.
|
ILX:0100390
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Affective neuroscience
|
Branch of neuroscience involving the study of the neural mechanisms of emotion.This interdisciplinary field combines neuroscience with the psychological study of personality, emotion, and mood. - definition adapted from Wikipedia
|
ILX:0100391
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Affective Psychotic Disorder
|
Disorders in which the essential feature is a severe disturbance in mood (depression, anxiety, elation, and excitement) accompanied by psychotic symptoms such as delusions, hallucinations, gross impairment in reality testing, etc. (MeSH).
|
ILX:0100392
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Afferent
|
An axon that is incoming into a brain region. Could also refer to the neuron that gives rise to the axon.(A connection, or a pathway to a node. A node can be an individual neuron, a neuron class, a gray matter region, or a site. Afferent and its complementary term efferent were used for the first time by Unzer, 1771, to indicate toward or away from the central nervous system or other non-neural tissues. Adapted from Swanson, 2014).
|
ILX:0100393
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Affinity chromotography instrument
|
|
ILX:0100394
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
African Biobank
|
A cryogenic storage facility located in Africa used to archive biological samples for use in research and experiments or transplantation. Ranging in size from individual refrigerators to warehouses, African biobanks are maintained by institutions such as hospitals, universities, nonprofit organizations, and pharmaceutical companies. (Adapted from Wikipedia)
|
ILX:0100395
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
African-American
|
Citizens or residents of the United States who have origins in any of the black populations of Africa. In the United States, the terms are generally used for Americans with at least partial Sub-Saharan African ancestry. Most African Americans are the direct descendants of captive Africans who survived the slavery era within the boundaries of the present United States, although some are–or are descended from–immigrants from African, Caribbean, Central American or South American nations. They make up the single largest racial minority in the United States and form the second largest racial group after whites in the United States. (Wikipedia)
|
ILX:0100396
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
After-potential
|
A transient hyperpolarization or depolarization following the action potential.
|
ILX:0100397
|
5
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Agalsidase beta
|
Recombinant human alpha-galactosidase A. The mature protein is composed of 2 subunits of 398 residues. Protein is glycosylated and produced by CHO cells Pharmacology: Used in the treatment of Fabry disease, an X-linked genetic disorder of glycosphingolipid metabolism. The disease is characterized by a deficiency of the lysosomal enzyme alpha-galactosidase A, which leads to progressive accumulation of glycosphingolipids, predominantly GL-3, in many body tissues. Clinical manifestations of Fabry disease include renal failure, cardiomyopathy, and cerebrovascular accidents. Fabrazyme is intended to provide an exogenous source of alpha-galactosidase A and to limit the accumulation of these glycolipids in the tissues. Mechanism of action: Alpha-galactosidase A catalyzes the hydrolysis of globotriaosylceramide (GL-3) and other a-galactyl-terminated neutral glycosphingolipids, such as galabiosylceramide and blood group B substances to ceramide dihexoside and galactose. Drug type: Approved. Biotech. Investigational. Drug category: Enzyme Replacement Agents
|
ILX:0100398
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Agarose gel electrophoresis instrument
|
|
ILX:0100399
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |